Medications for Ocular Hypertension

11 results
  • alphagan p - brimonidine tartrate solution/ drops

    (Brimonidine Tartrate)
    Allergan, Inc.
    Alphagan P (brimonidine tartrate 0.1% or 0.15%) is indicated to lower elevated intraocular pressure in adults with open-angle glaucoma or ocular hypertension.
  • combigan - brimonidine tartrate, timolol maleate solution/ drops

    (Brimonidine Tartrate, Timolol Maleate)
    Allergan, Inc.
    Combigan reduces elevated intraocular pressure (IOP) in adults with glaucoma or ocular hypertension when current therapy is inadequate. It combines brimonidine and timolol and is used as adjunctive or replacement IOP-lowering therapy.
  • cosopt pf - dorzolamide hydrochloride and timolol maleate solution/ drops

    (Dorzolamide Hydrochloride And Timolol Maleate)
    Thea Pharma Inc.
    Cosopt PF reduces elevated intraocular pressure in adults with open-angle glaucoma or ocular hypertension who have not achieved target IOP with beta-blocker therapy alone.
  • durysta - bimatoprost implant

    (Bimatoprost)
    Allergan, Inc.
    Durysta is an intracameral implant indicated to reduce intraocular pressure (IOP) in adults with open-angle glaucoma (OAG) or ocular hypertension (OHT).
  • lumigan - bimatoprost solution/ drops

    (Bimatoprost)
    Allergan, Inc.
    LUMIGAN (bimatoprost ophthalmic solution) 0.01% reduces elevated intraocular pressure in adults with open-angle glaucoma or ocular hypertension.
  • rhopressa - netarsudil solution/ drops

    (Netarsudil)
    Alcon Laboratories, Inc.
    Rhopressa is indicated to reduce elevated intraocular pressure (IOP) in adults with open-angle glaucoma or ocular hypertension.
  • rocklatan - netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% solution/ drops

    (Netarsudil And Latanoprost Ophthalmic Solution, 0.02%/0.005%)
    Alcon Laboratories, Inc.
    Rocklatan reduces elevated intraocular pressure (IOP) in adults with open-angle glaucoma or ocular hypertension. It combines a Rho kinase inhibitor and a prostaglandin F2α analogue in a fixed-dose formulation.